SCHEMBL4204342

SCHEMBL4204342

CCCCOC(=O)N1CCC(CC([NH])=O)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
GAA P10253 1/20 0.42
TPSAB1 Q15661 1/20 0.41
TPSD1 Q9BZJ3 1/20 0.41
TPSG1 Q9NRR2 1/20 0.41
ATM Q13315 2/20 0.39
THRB P10828 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HRH2 P25021 1/20 0.39
HRH1 P35367 1/20 0.39
CHRM1 P11229 2/20 0.39
CHRM2 P08172 1/20 0.39
MMP13 P45452 2/20 0.38
NOS3 P29474 1/20 0.38
NOS2 P35228 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
MMP9 P14780 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193447 0.86 LMNA (0.51) LMNAPOLBSMN1; SMN2GAATPSAB1
SCHEMBL7010085 0.85 SMN1; SMN2 (0.54) LMNAPOLBSMN1; SMN2GAATPSAB1
SCHEMBL13174683 0.84 POLB (0.52) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL29480884 0.84 LMNA (0.52) LMNAPOLBSMN1; SMN2GAATPSAB1
SCHEMBL29480883 0.84 LMNA (0.52) LMNAPOLBSMN1; SMN2GAATPSAB1
SCHEMBL4200215 0.83 POLB (0.46) LMNAPOLBSMN1; SMN2HRH2HRH1
SCHEMBL725320 0.83 LMNA (0.58) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL16256877 0.83 LMNA (0.58) LMNAPOLBSMN1; SMN2GAATPSAB1
SCHEMBL11974037 0.83 POLB (0.58) LMNAPOLBSMN1; SMN2GAAATM
SCHEMBL29924072 0.82 LMNA (0.54) LMNAPOLBSMN1; SMN2GAATPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029578-A1 2-CARBOCYCLOAMINO-4-IMIDAZ0LYLPYRIMIDINES AS AGENTS FOR THE INHBITION OF CELL PROLIFERATION AstraZeneca AB (SE) 2009-03-04 EP disclosed
WO-2007138277-A1 2-CARBOCYCLOAMINO-4-IMIDAZ0LYLPYRIMIDINES AS AGENTS FOR THE INHBITION OF CELL PROLIFERATION ASTRAZENECA AB (SE) 2007-12-06 WO disclosed